Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: Azithromycin and Ampicillin for Late PPROM [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating azithromycin and ampicillin for late preterm rupture of membranes is currently recruiting, led by Sheba Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMPICILLIN (AMPICILLIN)
  • Azithromycin (azithromycin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Pregnancy Complications, Infectious, Premature Birth | Phase 4 | Status: RECRUITING